SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010599
Filing Date
2017-05-12
Accepted
2017-05-11 18:10:11
Documents
70
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q orex-10q_20170331.htm 10-Q 1979267
2 EX-31.1 orex-ex311_9.htm EX-31.1 8105
3 EX-31.2 orex-ex312_7.htm EX-31.2 8428
4 EX-32.1 orex-ex321_8.htm EX-32.1 4546
5 EX-32.2 orex-ex322_6.htm EX-32.2 4706
  Complete submission text file 0001564590-17-010599.txt   7230670

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT orex-20170331.xml EX-101.INS 1512229
7 XBRL TAXONOMY EXTENSION SCHEMA orex-20170331.xsd EX-101.SCH 54244
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orex-20170331_cal.xml EX-101.CAL 65587
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orex-20170331_def.xml EX-101.DEF 199500
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE orex-20170331_lab.xml EX-101.LAB 410487
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orex-20170331_pre.xml EX-101.PRE 322821
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33415 | Film No.: 17835719
SIC: 2834 Pharmaceutical Preparations